Evidence map›Paper›PMID 39969512›Full record

ArticleeLife2025

Synovial macrophage diversity and activation of M-CSF signaling in post-traumatic osteoarthritis.

Alexander J Knights, Easton C Farrell, Olivia M Ellis, Michelle J Song, C Thomas Appleton, Tristan Maerz

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. [The role and mechanism of chemokine network in promoting osteoarthritis progression by regulating synovial macrophage heterogeneity].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2026
    Review
  7. Review
  8. How Selective are Nanomaterials to Treat Osteoarthritis.International journal of nanomedicine · 2026
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Advances in molecular imaging for osteoarthritis.Connective tissue research · 2025
    Review
  15. Developing anFrontiers in immunology · 2025
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Alexander J KnightsDepartment of Orthopaedic Surgery, University of Michigan, Ann Arbor, United States.ORCID https://orcid.org/0000-0001-8402-2212
Easton C FarrellDepartment of Orthopaedic Surgery, University of Michigan, Ann Arbor, United States.
Olivia M EllisDepartment of Orthopaedic Surgery, University of Michigan, Ann Arbor, United States.
Michelle J SongDepartment of Orthopaedic Surgery, University of Michigan, Ann Arbor, United States.
C Thomas AppletonDepartment of Physiology and Pharmacology, Western University, London, Canada.
Tristan MaerzDepartment of Orthopaedic Surgery, University of Michigan, Ann Arbor, United States.ORCID https://orcid.org/0000-0002-4523-6012

Funding

Precision Mapping of Knee Pain in Osteoarthritis: Understanding differences between pain with activity and restUC2AR082186 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI LOTZ, MARTIN K, MALFAIT, ANNE-MARIE · 2022 to 2025
$11.9M
Sustained Biomaterial-mediated Inhibition of R-spondin 2 to Target Pathological Wnt Signaling in Post-Traumatic OsteoarthritisR01AR080035 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Kurt David Hankenson · 2022 to 2026
$2.5M
Fibrosis, inflammation, and osteophyte formation in post-traumatic osteoarthritisR00AR081894 · NIAMS · WASHINGTON UNIVERSITY · PI Alexander John Knights · 2025 to 2026
$477k
Bioerodible corticosteroid microparticle-drug as an intra-articular drug delivery system for osteoarthritis therapyR21AR080502 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ENIOLA-ADEFESO, OMOLOLA, MAERZ, TRISTAN · 2022 to 2023
$405k
Targeting Pathological Angiogenesis after Joint InjuryR21AR076487 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALFORD, ANDREA I, MAERZ, TRISTAN · 2021 to 2021
$378k
Autonomous RUNX2 suppression in genetically modified stem cell-derived chondrocytes as a disease modifying therapeutic for PTOAR21AR082016 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COLEMAN, RHIMA, MAERZ, TRISTAN · 2023 to 2024
$356k
Fibrosis, inflammation, and osteophyte formation in post-traumatic osteoarthritisK99AR081894 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KNIGHTS, ALEXANDER JOHN · 2023 to 2024
$206k
Congressionally Directed Medical Research Programs HT94252310327NIAMS NIH HHS K99 AR081894NIAMS NIH HHS K99AR081894NIAMS NIH HHS R00 AR081894NIAMS NIH HHS R01 AR080035NIAMS NIH HHS R01AR080035NIAMS NIH HHS R21 AR076487NIAMS NIH HHS R21AR076487NIAMS NIH HHS R21 AR080502NIAMS NIH HHS R21 AR082016NIAMS NIH HHS UC2 AR082186NIH HHS R21AR080502NIH HHS R21AR082016Ralph and Marian Falk Medical Research Trust Catalyst Award
6 · The paper itself

Abstract

Synovium is home to immune and stromal cell types that orchestrate inflammation following a joint injury; in particular, macrophages are central protagonists in this process. We sought to define the cellular and temporal dynamics of the synovial immune niche in a mouse model of post-traumatic osteoarthritis (PTOA), and to identify stromal-immune crosstalk mechanisms that coordinate macrophage function and phenotype. We induced PTOA in mice using a non-invasive tibial compression model of anterior cruciate ligament rupture (ACLR). Single-cell RNA-sequencing and flow cytometry were used to assess immune cell populations in healthy (Sham) and injured (7 and 28 days post-ACLR) synovium. Characterization of synovial macrophage polarization states was performed, alongside computational modeling of macrophage differentiation, as well as implicated transcriptional regulators and stromal-immune communication axes. Immune cell types are broadly represented in healthy synovium, but experience drastic expansion and speciation in PTOA, most notably in the macrophage portion. We identified several polarization states of macrophages in synovium following joint injury, underpinned by distinct transcriptomic signatures, and regulated in part by stromal-derived macrophage colony-stimulating factor signaling. The transcription factors Pu.1, Cebpα, Cebpβ, and Jun were predicted to control differentiation of systemically derived monocytes into pro-inflammatory synovial macrophages. In summary, we defined different synovial macrophage subpopulations present in healthy and injured mouse synovium. Nuanced characterization of the distinct functions, origins, and disease kinetics of macrophage subtypes in PTOA will be critical for targeting these highly versatile cells for therapeutic purposes.

Indexed as

Macrophage Colony-Stimulating FactorMacrophagesOsteoarthritisSignal TransductionSynovial MembraneAnimalsDisease Models, AnimalMaleMiceMice, Inbred C57BLMacrophage Colony-Stimulating Factorimmunologyinflammationjoint injurymacrophagesmouseosteoarthritissingle-cell RNA-seqsynovium

Identifiers

PMID39969512
PMCPMC11839164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.